Influence of pro- and prebiotics on gastric, duodenal and colonic bioaccessibility of the mycotoxin beauvericin

Journal of Food Composition and Analysis

Volumn 32, Issue 2, 2013, Pages 141-149

  Mallebrera, B ^a   Meca, G ^a   Manyes, L ^a   Manes J ^a   Font, G ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Beauvericin; Bioaccessibility; Food analysis; Food composition; Food processing; Food safety; Gastrointestinal digestion; LC MS; Liquid chromatography mass spectrometry; Prebiotic; Prebiotic compounds; Probiotic; Probiotic strains; Risk evaluation

Indexed keywords

EID: 84888032783     PISSN: 08891575     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfca.2013.09.003     Document Type: Article

References (31)

1. Awad W.A., Ghareeb K., Bohm J. Animal feed additive and the effect of the Fusarium toxin deoxynivalenol on the electrophysiological measurements of transepithelial ion transport of young chickens with using chamber technique. Journal of Poultry Science 2009, 1:25-27.
2. Baines D., Erb S., Lowe R., Turkington K., Sabau E., Kuldau G., Juba J., Masson L., Mazza A., Roberts R. A prebiotic, Celmanax™, decreases Escherichia coli O157:H7 colonization of bovine cells and feed-associated cytotoxicity in vitro. BMC Research Notes 2011, 4:110-115.
3. Calo L., Fornelli F., Ramires R., Nenna S., Tursi A., Caiaffa M.F., Macchia L. Cytotoxic effects of the mycotoxin Beauvericin to human cell lines of myeloid origin. Pharmacological Research 2004, 49:73-77.
4. Carolien H.M., Versantvoort H., Oomen A.G., Van de Kamp E., Rompelberg C.J.M., Adrienne J.A.M. Sips Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food. Food and Chemical Toxicology 2005, 43:31-40.
5. FAO WHO Guidelines for the Evaluation of Probiotics in Food 2002, 1-11. Food and Agriculture Organization of the United Nations and World Health Organization Working Group Report, London, Ontario.
6. Fernández-García E., Carvajal-Lérida I., Pérez-Gálvez A. In vitro bioaccessibility assessment as a prediction tool of nutritional efficiency. Nutrition Research 2009, 29:751-760.
7. Figueroa-Gonzalez I., Quijano G., Ramirez G., Cruz-Guerrero A. Probiotics and prebiotics: perspectives and challenges. Journal of the Science of Food and Agriculture 2011, 91:1341-1348.
8. Gil-Izquierdo A., Zafrilla P., Tomás-Barberá F.A. An in vitro method to simulate phenolic compound release from the food matrix in the tract. European Food Research and Technology 2002, 214:155-159.
9. Jestoi M. Emerging Fusarium-Mycotoxins Fusaproliferin, Beauvericin, Enniatins, and Moniliformin - a review. Critical Review in Food Science and Nutrition 2008, 48:21-49.
10. Jow G.M., Chou C.J., Chen B.F., Tsai J.H. Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium. Cancer Letters 2004, 216:165-173.
11. Kabak B., Brandon E.F.A., Var I., Blokland M., Sips A.J.A.M. Effects of probiotic bacteria on the bioaccessibility of aflatoxin b1 and ochratoxin a using an in vitro digestion model under fed conditions. Journal of Environmental Science and Health 2009, 44:472-480.
12. Kabak B., Ozbey F. Assessment of the bioaccessibility of aflatoxins from various food matrices using an in vitro digestion model, and the efficacy of probiotic bacteria in reducing bioaccessibility. Journal of Food Composition and Analysis 2012, 27:21-31.
13. Kokkonen M., Ojala L., Parikka P., Jestoi M. Mycotoxin production of selected Fusarium species at different culture conditions. International Journal of Food Microbiology 2010, 143:17-25.
14. Kumar M., Kumar A., Nagpal R. Cancer-preventing attributes of probiotics: an update. International Journal of Food Science and Nutrition 2010, 61:473-496.
15. Kumar M., Verma V., Nagpal R., Kumar A., Behare P.V., Singh B., Aggarwal P.K. Anticarcinogenic effect of probiotic fermented milk and Chlorophyllin on aflatoxin-B1 induced liver carcinogenesis in rats. British Journal of Nutrition 2011, 107:1006-1016.
16. Logrieco A., Moretti A., Castella G., Kostecki M., Golinski P., Ritieni A., Chelkowski J. Beauvericin production by Fusarium species. Applied and Environmental Microbiology 1998, 64:3084-3088.
17. Meca G., Zinedine A., Blesa J., Font G., Mañes J. Further data on the presence of Fusarium emerging mycotoxins Enniatins, fusaproliferin and Beauvericin in cereals available on the Spanish markets. Food and Chemical Toxicology 2010, 48:1412-1416.
18. Meca G., Meneghelli G., Ritieni A., Mañes J., Font G. Influence of different soluble dietary fibers on the bioaccessibility of the minor Fusarium mycotoxin beauvericin. Food and Chemical Toxicology 2012, 50:1362-1368.
19. Meca G., Ritieni A., Mañes J. Reduction in vitro of the minor Fusarium mycotoxin beauvericin employing different strains of probiotic bacteria. Food Control 2012, 28:435-440.
20. Nagpal R., Yadav H., Puniya A.K., Singh K., Jain S., Marotta F. Potential of probiotics and prebiotics for symbiotic functional dairy foods. International Journal of Probiotics and Prebiotics 2007, 2:75-84.
21. Nagpal R., Kumar A., Arora S. In-vitro probiotic potential of lactobacilli from indigenous milk products. International Journal of Probiotics and Prebiotics 2010, 5:103-110.
22. Pineiro M., Asp N.G., Reid G., Macfarlane S., Morelli L., Brunser O. FAO Technical meeting on Prebiotics. Journal of Clinical Gastroenterology 2008, 42:156-159.
23. Ritieni A., Moretti A., Logrieco A., Bottalico A., Randazzo G., Monti S.M., Ferracane R., Fogliano V. Occurrence of fusaproliferin, fumonisinB1 and beauvericin inmaize from Italy. Journal of Agricultural and Food Chemistry 1997, 45:4011-4016.
24. Ruiz M.J., Franzova P., Juan-García A., Font G. Toxicological interactions between the mycotoxins beauvericin, deoxynivalenol and T-2 toxin in CHO-K1 cells in vitro. Toxicon 2011, 58:315-326.
25. Ruiz M.J., Macáková P., Juan-García A., Font G. Cytotoxic effects of mycotoxin combinations in mammalian kidney cells. Food and Chemical Toxicology 2011, 49:2718-2724.
26. Salminen S.J., Gueimonde M., Isolauri E. Probiotics that modify disease risk. Journal of Nutrition 2005, 11294-11298.
27. Sorensen J.L., Nielsen K.F., Rasmussen P.H., Thrane U. Development of a LC-MS/MS method for the analysis of Enniatins and Beauvericin in whole fresh and ensiled maize. Journal of Agricultural and Food Chemistry 2008, 56:10439-10443.
28. Tomoda H., Huang X.-H., Cao J., Nishida H., Nagao R., Okuda S., Tanaka H., Omura S., Arai H., Inoue K. Inhibition of acyl-CoA: cholesterol acyltransferase activity by cyclodepsipeptide antibiotics. Journal of Antibiotics 1992, 45:1626-1632.
29. Uhlig S., Torp M., Heier B.T. Beauvericin and Enniatin A, A1, B and B1 in Norwegian grain: a survey. Food Chemistry 2006, 94:193-201.
30. Waskiewicz A., Golinski P., Karolewski Z., Irzykowska L., Bocianowski J., Kostecki M., Weber Z. Formation of fumonisins and other secondary metabolites by Fusarium oxysporum and F. proliferatum: a comparative study. Food Additives and Contaminants 2010, 5:608-615.
31. Yadav H., Jain S., Sinha P.R. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei ameliorated the Streptozotocin-induced oxidative stress and dyslipidemia in rats. Journal of Dairy Research 2008, 75:189-195.